t-2 toxin has been researched along with Cardiomyopathies, Primary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Jaćević, V; Kuča, K; Nepovimova, E; Wu, Q | 1 |
Guo, P; Hu, S; Lu, Q; Ren, Z; Wang, X; Wu, Q; Zhu, X | 1 |
More, R; Sherman, Y; Yagen, B; Yarom, R | 1 |
3 other study(ies) available for t-2 toxin and Cardiomyopathies, Primary
Article | Year |
---|---|
Cardiomyopathy induced by T-2 toxin in rats.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Glycogen; Male; Mast Cells; Myocardium; Myocytes, Cardiac; Rats, Wistar; T-2 Toxin | 2020 |
PPAR-γ with its anti-fibrotic action could serve as an effective therapeutic target in T-2 toxin-induced cardiac fibrosis of rats.
Topics: Anilides; Animals; Cardiomyopathies; Cell Line; Collagen; Fibrosis; Male; Myocardium; Pioglitazone; PPAR gamma; Rats, Wistar; Signal Transduction; T-2 Toxin; Transforming Growth Factor beta1; Up-Regulation | 2021 |
T-2 toxin-induced pathology in the hearts of rats.
Topics: Animals; Cardiomyopathies; Edema, Cardiac; Hyperplasia; Male; Microscopy, Electron; Myocardium; Rats; Sesquiterpenes; T-2 Toxin | 1983 |